IMS Health, a leading worldwide provider of information, technology and
services dedicated to making healthcare perform better, has launched
AppScript, an mHealth app prescribing solution designed to help
healthcare providers and health plans create proprietary formularies
based on an objective assessment of healthcare app functionality and
value.
The company also announced the launch of AppNucleus, its
customizable, cloud-based hosting platform that will enable developers
to build secure, industry-compliant healthcare apps at very low cost.
Both new products will leverage IMS Health’s comprehensive data on
diseases, treatments, costs and outcomes. The solutions address the
growing demand for secure mobile apps that drive patient engagement and
enhance the delivery of care.
The AppScript Software-as-a-Service
solution classifies and evaluates more than 40,000 mobile healthcare
apps currently available for download on iOS and Android platforms,
categorized by stage of the patient journey. Each app is assessed using
the company’s proprietary IMS Health AppScore, which ranks apps based on
functionality, peer and patient reviews, certifications, and their
potential to improve outcomes and lower the cost of care. As part of
wellness, prevention and treatment regimens, physicians can organize
these apps into formularies based on their specific patient population
and practice preferences. In addition, AppScript enables them to
securely prescribe, reconcile and track app use by patients from any
mobile interface.
AppNucleus is the company’s innovative
healthcare app development and hosting platform that makes it easier for
app developers to offer HIPAA- and HITECH-compliant solutions. The
platform, compatible with all mobile operating systems, uniquely
integrates IMS Health information and analytics at every stage of app
development to support design and performance evaluation decisions.
AppNucleus features a suite of plug-and-play solutions, enabling
patients and physicians to exchange health information on mobile devices
via a secure, encrypted channel to protect patient information. It also
offers app developers a highly economical way to build security into
their apps and protect patient information.
“Today, there is
growing recognition of mobile health’s potential to transform healthcare
– to advance doctor/patient engagement and empower consumers to better
monitor and manage their own health,” said Stefan Linn, senior vice
president, Strategy & Global Pharma Solutions, IMS Health. “That
potential can only be realized through a systematic evaluation of the
clinical benefits of healthcare apps, clear professional guidelines
around their use, and effective integration of apps with other aspects
of patient care. With these game-changing solutions, IMS Health is
establishing an intelligent, secure infrastructure for mobile health,
backed by our market-leading real-world evidence capabilities and the
most advanced technology platform in healthcare.”
The launch of
AppScript and AppNucleus is a key step in IMS Health’s efforts to
deliver connected healthcare solutions that leverage the company’s
intelligent cloud and extensive information assets to inform strategic
decisions, reduce costs and improve the quality of care.
